Table_8_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_9_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_4_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_7_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_13_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_10_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_6_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_2_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_3_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Table_11_Trends of serum 25(OH) vitamin D and association with cardiovascular disease and all-cause mortality: from NHANES survey cycles 2001–2018.docx by Changlun Hu (17891735)

“…¹</p>Results<p>Survey data from 2001 to 2018 revealed a rise in serum 25(OH)D levels, from a weighted mean (95% CI) of 65.6 (63.8–67.4) nmol/L during 2001–2002 to 73.5 (70.4–76.5) nmol/L during 2017–2018, among US adults, while overall vitamin D deficiency rates remained stable (p = 0.152). …”

Gemcitabine and ATR inhibitor synergism and effects on the cell cycle and DNA damage in U-CHCF365 and UM-Chor1 (Batch 1) by Chordoma Foundation (4391989)

“…U-CHCF365 and UM-Chor1 cells were plated in a black walled, glass bottom, 96-well plate at 5,000 cells/well and 1,500 cells/well, respectively. …”

Interaction between SSVEP power and alpha power and the proposed mechanism of interaction. by Liyu Cao (786645)

“…Consequently, SSVEP and behavioural detection rate (both exclusively probed and introduced in the central part of the visual field marked by the black circle) will decrease. The original data are available from <a href="https://doi.org/10.6084/m9.figshare.9094742.v1" target="_blank">https://doi.org/10.6084/m9.figshare.9094742.v1</a>. …”

Antiangiogenic activity of photobiomodulation in experimental model using chorioallantoic embryonic membrane of chicken eggs by Lays Fernanda Nunes Dourado (6098738)

“…We treated the negative control group with 50 μl phosphate-buffered-saline (pH 7.4) and the positive control group (Beva) with 50 μl bevacizumab solution (Avastin, Produtos Roche Químicos e Farmacêuticos, S.A., Brazil). Results: We found a decrease in total vessel length in the Beva group (24.96% ± 12.85%) and in all the groups that received 670 nm red light therapy (2× group, 34.66% ± 8.66%; 4× group, 42.42% ± 5.26%; 8× group, 38.48% ± 6.96%), compared with the negative control group. …”

Peptide interactions with di-8-ANEPPS labeled LUV and cell membranes. by Axel Hollmann (397503)

“…Dashed curves represent the fitting to the single binding site equation (eq. 5). Affinity parameters for the cells are indicated in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0060302#pone-0060302-t003" target="_blank">Table 3</a>. …”

Intrinsic Patterns of Coupling between Correlation and Amplitude of Low-Frequency fMRI Fluctuations Are Disrupted in Degenerative Dementia Mainly due to Functional Disconnection by Daniele Mascali (5450159)

“…Our results indicate that degenerative dementia is characterized by a loss of global connection rather than by a decrease of fluctuation amplitude.…”

Bioenergetic profile of human coronary artery smooth muscle cells and effect of metabolic intervention by Mingming Yang (284445)

“…Stress tests also showed that oxidative phosphorylation and glycolysis can increase to a maximum of 3.5 fold and 1.25 fold, respectively, indicating that the former has a high reserve capacity. …”

Susceptibility to HIV-1 infection in primary macrophages depends on differentiation stimuli. by Roger Badia (482283)

“…<p><b>(A)</b> Evaluation of cell proliferation by Ki67 staining. …”

Functional study of moDC maturation. by Laurent Gorvel (279197)

“…<b>B</b>, moDCs stimulated with <i>T. whipplei</i> (a), <i>B. abortus</i> (b), <i>C. burnetii</i> (c), <i>O. tsutsugamushi</i> (d) or <i>E. coli</i> LPS (e) were co-cultured with CFSE-labeled autologous T-lymphocytes for 5 days. …”

Thapsigargin-induced differentiation is associated with increased KGFR expression. by Francesca Belleudi (233982)

“…<p>(A) HaCaT cells were treated with TG 0.5 µM for 1 h at 37°C following by incubation at 37°C for 48 h. …”

Administration of CORM-2 does not improve m-RCT in vivo in diabetic mice. by Karen Alejandra Méndez-Lara (5819492)

“…In all panels, results are the mean ± SEM of 5 mice and are expressed in % vs. injected dose. …”